NewAge Industries, Inc., a prominent player in the fluid transfer systems industry, has announced the appointment of Mary Marcus as its new Chief Executive Officer. This strategic move comes as the company, known for its AdvantaPure and NewAge Performance Products brands, seeks to strengthen its position in the global biopharma and industrial markets.
Marcus, who has been with NewAge Industries since 2008, brings a wealth of experience to her new role. Her journey within the company has been marked by a series of leadership positions in operational functions, which have been instrumental in navigating the company through periods of significant growth and industry challenges. Her appointment as CEO follows a successful tenure as Interim CEO & General Manager, during which she demonstrated her ability to lead the organization and position it strategically within the industry.
The decision to elevate Marcus to the role of CEO has been met with enthusiasm from the company's board. Andreas Georghiou, Lead Director of the Board, praised Marcus's contributions, stating that she has been a vital part of NewAge Industries and has successfully led the organization while positioning it as a global leader with substantial growth potential. Ken Baker, the previous CEO and current board member, also expressed his support for Marcus's appointment, citing her commitment and dedication to the company, its team members, and global partners.
Marcus's background in supply chain operations and her subsequent roles in various operational functions have equipped her with a comprehensive understanding of the company's operations. Her leadership has been particularly notable in establishing and developing Single Use Sterilization programs, overseeing the construction of cleanroom production suites, managing the Quality Management System, and expanding the company's global footprint with the launch of a new manufacturing site in Europe earlier this year.
The appointment of Marcus as CEO is significant for several reasons. Firstly, it represents a continuation of leadership from within the company, ensuring a smooth transition and maintaining institutional knowledge. Secondly, Marcus's extensive experience in operational roles positions her well to address the complex challenges faced by the fluid transfer systems industry, particularly in the rapidly evolving biopharma sector. Her understanding of the company's operations and the industry landscape will be crucial in driving innovation and maintaining NewAge Industries' competitive edge.
Furthermore, this leadership change comes at a time when the biopharma industry is experiencing significant growth and transformation. As CEO, Marcus will be responsible for guiding NewAge Industries through these industry shifts, capitalizing on new opportunities, and ensuring the company's continued success in providing high-quality fluid transfer solutions to its global clientele.
NewAge Industries' status as an employee-owned corporation (ESOP) with a Gold Ecovadis Sustainability Rating and B Corporation certification adds another layer of importance to this appointment. Marcus will be tasked with maintaining and enhancing the company's commitment to sustainability and ethical business practices, which are increasingly important factors in the biopharma and industrial sectors.
As NewAge Industries enters this new chapter under Marcus's leadership, the industry will be watching closely to see how the company evolves and adapts to meet the changing needs of its markets. With her track record of success within the company and her comprehensive understanding of its operations, Mary Marcus is well-positioned to lead NewAge Industries into a future of continued growth and innovation in the fluid transfer systems industry.
